Emerging therapies for non-small cell lung cancer

Emerging therapies for non-small cell lung cancer

Abstract Recent advances in the field of novel anticancer agents prolong patients’ survival and show a promising future. Tyrosine kinase inhibitors and immunotherapy for lung cancer are the two major areas undergoing rapid development. Although increasing novel anticancer agents were innovated, how...

Full description

Bibliographic Details
Main Authors: Chao Zhang, Natasha B. Leighl, Yi-Long Wu, Wen-Zhao Zhong
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Journal of Hematology & Oncology
Subjects:
Tyrosine kinase inhibitors
Checkpoint inhibitors
CAR-T
Bispecific antibodies
Lung cancer
Online Access:http://link.springer.com/article/10.1186/s13045-019-0731-8

Internet

http://link.springer.com/article/10.1186/s13045-019-0731-8

Similar Items